Management of Gingivitis: Contemporary Approaches and Recent Therapeutic Advancements
- Autores: Girbane Y.1, Wal P.2, Khare R.2, Sarkar S.3, Bhise M.4, Singh V.5, Tyagi L.6, Wal A.2
- 
							Afiliações: 
							- Department of Pharmacy, VSS Institute of Pharmacy, Badnapur, Dist. Jalna, 431202, India
- Department of Pharmacy, PSIT -Pranveer Singh Institute of Technology, NH 19 Kanpur Agra highway Bhaunti Kanpur, Uttar Pradesh, India
- Department of Pharmacy, BCDA College of Pharmacy and Technology, Hridaypur, Barasat, Kolkata, India
- Department of Pharmacy, SGSPS, Institute of Pharmacy, Akola (MS), India
- Department of Pharmacy, Sainik Pharmacy College, Prayagraj, Uttar Pradesh, India
- Department of Pharmacy, Lloyd Institute of Management and Technology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, India
 
- Edição: Volume 22, Nº 5 (2024)
- Seção: Medicine
- URL: https://rjeid.com/2211-3525/article/view/642328
- DOI: https://doi.org/10.2174/0122113525287883240312084729
- ID: 642328
Citar
Texto integral
Resumo
Background:Gingivitis, commonly known as gum disease, refers to several types of inflammatory diseases that impact the connective tissues that surround the teeth. Gingivitis causes swelling, redness, and bleeding of the gums in its early stages.
Objective:This article aims to describe the standard gingivitis medication. It emphasizes recent advancements in the initial therapy, treatment, and healing mechanisms of gingivitis for achievement in the clinical testing of medicines that promise to enable disease modification in patients. Also, it aims to review recent advancements and emerging therapeutic developments in the management of gingivitis, including gene-based therapies, nanotherapies, anti-cytokine therapies, stem cell-based therapies, and probiotic therapies.
Methods:The information for the review articles was acquired by using Google Scholar and PubMed as search engines, as well as a number of publishers, including Springer Nature, Ben-tham Science, Taylor & Francis, Elsevier, and Frontier.
Result and Discussion:Gingivitis is a gum disease and scaling root planning (SRP) is now the most common kind of periodontitis therapy available. It has the potential to deliver significant therapeutic success, but it can also have substantial problems that reduce the quality of life of a patient. Stem cell therapies, gingivitis genetic engineering, nuclear-based medicines, and other advances have given people hope that a wide range of illnesses, especially genetic disorders, can be cured.
Conclusion:The current gingivitis therapies are successful and continually evolving, with sev-eral drugs currently in clinical trials. These innovative medicines, when combined, may alter gingivitis treatment in the next few years. Finally, gingivitis therapy requires professional dental care and patient education on oral hygiene. Nonetheless, further research and clinical studies are necessary to validate the efficacy, safety, and long-term benefits of these novel treatment modalities.
Sobre autores
Yuvraj Girbane
Department of Pharmacy, VSS Institute of Pharmacy, Badnapur, Dist. Jalna, 431202, India
														Email: info@benthamscience.net
				                					                																			                												                														
Pranay Wal
Department of Pharmacy,PSIT -Pranveer Singh Institute of Technology, NH 19 Kanpur Agra highway Bhaunti Kanpur, Uttar Pradesh, India
														Email: info@benthamscience.net
				                					                																			                												                														
Riya Khare
Department of Pharmacy,PSIT -Pranveer Singh Institute of Technology, NH 19 Kanpur Agra highway Bhaunti Kanpur, Uttar Pradesh, India
														Email: info@benthamscience.net
				                					                																			                												                														
Sanjiban Sarkar
Department of Pharmacy, BCDA College of Pharmacy and Technology, Hridaypur, Barasat, Kolkata, India
														Email: info@benthamscience.net
				                					                																			                												                														
Manish Bhise
Department of Pharmacy, SGSPS, Institute of Pharmacy, Akola (MS), India
														Email: info@benthamscience.net
				                					                																			                												                														
Virendra Singh
Department of Pharmacy, SainikPharmacy College, Prayagraj, Uttar Pradesh, India
														Email: info@benthamscience.net
				                					                																			                												                														
Lalit Tyagi
Department of Pharmacy, Lloyd Institute of Management andTechnology, Plot No.-11, Knowledge Park-II, Greater Noida, Uttar Pradesh, India
														Email: info@benthamscience.net
				                					                																			                												                														
Ankita Wal
Department of Pharmacy,PSIT -Pranveer Singh Institute of Technology, NH 19 Kanpur Agra highway Bhaunti Kanpur, Uttar Pradesh, India
							Autor responsável pela correspondência
							Email: info@benthamscience.net
				                					                																			                												                														
Arquivos suplementares
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail 